Grossly-resected synovial sarcoma treated by the German and Italian Pediatric Soft Tissue Sarcoma Cooperative Groups: discussion on the role of adjuvant therapies.
about
Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma.Sparing strategy does not compromise prognosis in pediatric localized synovial sarcoma: experience of the International Society of Pediatric Oncology, Malignant Mesenchymal Tumors (SIOP-MMT) Working Group.Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005).Synovial sarcoma in patients under 20 years of age: a multicenter study with a minimum follow-up of 10 years.Current management of pediatric soft tissue sarcomas.Role of chemotherapy in pediatric nonrhabdomyosarcoma soft-tissue sarcomas.The clinical implication of SS18-SSX fusion gene in synovial sarcoma.Outcome and the effect of age and socioeconomic status in 1318 patients with synovial sarcoma in the English National Cancer Registry: 1985-2009.Pharmacotherapy for pediatric soft-tissue sarcomas.The challenge of access to care for soft tissue sarcomas bridging pediatric and adult age: the Italian pediatric oncology view.Synovial sarcoma is a gateway to the role of chromatin remodeling in cancer.Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: A joint analysis from the European paediatric soft tissue sarcoma Study Group and the Children's Oncology Group.Pediatric and adolescent synovial sarcoma: multivariate analysis of prognostic factors and survival outcomes.Primary Metastatic Synovial Sarcoma: Experience of the CWS Study Group.Clinical features, treatment, and outcome in 102 adult and pediatric patients with localized high-grade synovial sarcoma.Prognostic factors and clinical outcomes in synovial sarcoma of the extremities.Pan-European Sarcoma Trials: Moving Forward in a Climate of Increasing Economic and Regulatory Pressure.Risk Factors Including Age, Stage and Anatomic Location that Impact the Outcomes of Patients with Synovial Sarcoma.
P2860
Q33660219-CA6D3B4F-47E0-4724-A9CC-126C5BFD2713Q33873982-7CD7681B-5119-4B95-8B31-BB239DE8B694Q34666948-08D9343A-6A89-4985-B43D-BE9CC846D01DQ35230631-81722BAE-0AA8-4C49-8A9D-89C6C69E9EBFQ36262280-85A9CD31-1D0C-49CE-875D-1742ADCA2479Q37183459-5ADFDDD5-A48E-402B-B821-36CC0A9D77E3Q37235515-531A6AD1-F5EB-4FD3-BEB3-52E5AEDDA1D3Q37350221-1CBDA6C7-B006-438F-81BA-5A47959E2DD3Q37838445-A20F1400-C159-426F-8A2A-D4BC6DB9E190Q37982451-4C377D60-A7F1-43BF-964C-DAF3ECDB04ACQ38567366-EF709A24-8DE7-4897-9369-015ED6833632Q38846323-3F0E374F-9E7B-4D5A-8DA8-D93C6616159BQ39571802-0FFFEE22-41BE-4B25-8900-F1FCE1B0EB48Q39898636-520357B5-51F0-4332-87F2-5A76D63CEDB9Q41963479-38D447D5-1E15-4818-B8AD-BC40785C702AQ43918357-682AA704-010A-42FA-90E2-B97212D4DFC9Q46110675-58BFC68D-5611-4C44-96D1-E70FC61AAD82Q55260657-8D92DD05-08F3-47D4-B8DC-6F21BF99B046
P2860
Grossly-resected synovial sarcoma treated by the German and Italian Pediatric Soft Tissue Sarcoma Cooperative Groups: discussion on the role of adjuvant therapies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Grossly-resected synovial sarc ...... he role of adjuvant therapies.
@ast
Grossly-resected synovial sarc ...... he role of adjuvant therapies.
@en
type
label
Grossly-resected synovial sarc ...... he role of adjuvant therapies.
@ast
Grossly-resected synovial sarc ...... he role of adjuvant therapies.
@en
prefLabel
Grossly-resected synovial sarc ...... he role of adjuvant therapies.
@ast
Grossly-resected synovial sarc ...... he role of adjuvant therapies.
@en
P2093
P50
P356
P1476
Grossly-resected synovial sarc ...... the role of adjuvant therapies
@en
P2093
Adrian C Mattke
Andreas Schuck
Christoph Int-Veen
Ewa Koscielniak
Ines B Brecht
Joern Treuner
Modesto Carli
P356
10.1002/PBC.20502
P577
2006-01-01T00:00:00Z